Skip to Content

AIDA Pharmaceuticals Inc AIDA

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AIDA is trading at a 37% discount.
Price
$0.00
Fair Value
$4.13
Uncertainty
Extreme
1-Star Price
$6.18
5-Star Price
$1.83
Economic Moat
Ndwrh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AIDA is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$5,400.00
Volume/Avg
35,000 / 18,500

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

AIDA Pharmaceuticals Inc is engaged in the development, production and distribution of antibiotics, cardiovascular and anti cancer drugs, in the form of powder for injection, liquid for intravenous injection, capsule, tablet, ointment and others within PRC.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
450

Valuation

Metric
AIDA
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
AIDA
Quick Ratio
0.50
Current Ratio
0.73
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
AIDA
Return on Assets (Normalized)
−3.30%
Return on Equity (Normalized)
−20.54%
Return on Invested Capital (Normalized)
−3.99%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRClcfrtwjrDcjjtj$70.5 Bil
ZTS
Zoetis Inc Class AXpmcrktwNvhqt$69.4 Bil
HLN
Haleon PLC ADRVpgkllsmSnqx$36.6 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRFpzcmqkdBqvd$14.9 Bil
VTRS
Viatris IncBstvglfQfdzf$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRKjrcwwdcPflgj$12.0 Bil
CTLT
Catalent IncYfntggbwqKmhbqp$10.1 Bil
PRGO
Perrigo Co PLCRrqnzbpsFtwf$4.1 Bil
CURLF
Curaleaf Holdings IncCfrsrxwpTsrnv$3.7 Bil
PBH
Prestige Consumer Healthcare IncMwxmhwrysClqbpy$3.4 Bil

Sponsor Center